{"id":"W2516958630","doi":"10.1016/j.cgh.2016.08.019","title":"Thalidomide in Refractory Crohn’s Disease: Risk-Benefit Ratio","year":2016,"lang":"en","type":"letter","venue":"Clinical Gastroenterology and Hepatology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Thalidomide; Medicine; Infliximab; Crohn's disease; Azathioprine; Inflammatory bowel disease; Refractory (planetary science); Internal medicine; Gastroenterology; Disease; Surgery; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00113933,0.0003530227,0.001208965,0.0004640221,0.0002797609,0.001288045,0.0003805689,0.002715218,0.003668406],"category_scores_gemma":[0.01178073,0.0001595183,0.0009099364,0.0004252633,0.0004497105,0.0009506344,0.0002831327,0.003526758,0.000803902],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00184772,"about_ca_system_score_gemma":0.0006363698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006044625,"about_ca_topic_score_gemma":0.001302325,"domain_scores_codex":[0.9991004,0.0004504593,0.00008648875,0.00007785617,0.0001807817,0.0001039387],"domain_scores_gemma":[0.9967482,0.002576283,0.0002245542,0.00005231796,0.0001411511,0.0002574132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05160656,0.0007861916,0.05405006,0.001895778,0.002859666,0.01926667,0.0001787181,0.00589128,0.00705697,0.02118943,0.1617467,0.673472],"study_design_scores_gemma":[0.07633948,0.01440635,0.1580967,0.004402944,0.01195414,0.09440224,0.001001217,0.03126775,0.007489295,0.2187658,0.381397,0.0004771208],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1425443,0.1630791,0.003060472,0.6319369,0.007047617,0.0002210502,0.0006655453,0.0001780367,0.05126697],"genre_scores_gemma":[0.8202577,0.03720006,0.002295714,0.1060075,0.02871693,0.0001318847,0.0003666032,0.00004304493,0.00498067],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.003668406,"threshold_uncertainty_score":0.01340616,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03936071371977981,"score_gpt":0.3552186452159418,"score_spread":0.3158579314961619,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}